Feed aggregator

Otsuka’s Centanafadine Shows Promise in Phase III Pediatric ADHD Studies

Biospace news - Mon, 10/30/2023 - 02:00
Otsuka’s Centanafadine Shows Promise in Phase III Pediatric ADHD Studies 10/30/2023

JLABS @ NYC Celebrates Its 5th Year in the Big Apple

Biospace news - Mon, 10/30/2023 - 02:00
JLABS @ NYC Celebrates Its 5th Year in the Big Apple 10/30/2023

Embattled Researchers See Path Forward for Anti-CD47 Cancer Drugs

Biospace news - Mon, 10/30/2023 - 02:00
Embattled Researchers See Path Forward for Anti-CD47 Cancer Drugs 10/30/2023

Psychedelics Poised for the Therapeutic Mainstream

Biospace news - Mon, 10/30/2023 - 02:00
Psychedelics Poised for the Therapeutic Mainstream 10/30/2023

Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway

Biospace news - Fri, 10/27/2023 - 02:00
Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway 10/27/2023

Sanofi Plans Spin-Off of Consumer Business, Lowers Profit Outlook

Biospace news - Fri, 10/27/2023 - 02:00
Sanofi Plans Spin-Off of Consumer Business, Lowers Profit Outlook 10/27/2023

Lilly’s Ulcerative Colitis Therapy Mirikizumab Finally Snags FDA Approval

Biospace news - Fri, 10/27/2023 - 02:00
Lilly’s Ulcerative Colitis Therapy Mirikizumab Finally Snags FDA Approval 10/27/2023

Merck Touts Strong Growth in Keytruda Sales, ADC Business in Q3

Biospace news - Fri, 10/27/2023 - 02:00
Merck Touts Strong Growth in Keytruda Sales, ADC Business in Q3 10/27/2023

FDA Approves Novel Corticosteroid Treatment Option for DMD Patients

Biospace news - Fri, 10/27/2023 - 02:00
FDA Approves Novel Corticosteroid Treatment Option for DMD Patients 10/27/2023

Augmenting the Regulatory Worker: Are We Making Them Better or Worse?

Biospace news - Fri, 10/27/2023 - 02:00
Augmenting the Regulatory Worker: Are We Making Them Better or Worse? 10/27/2023

Opinion: How AI Can Accelerate and Improve Clinical Trial Recruitment

Biospace news - Fri, 10/27/2023 - 02:00
Opinion: How AI Can Accelerate and Improve Clinical Trial Recruitment 10/27/2023

BMS Pushes Back Target Sales for New Drugs as Q3 Revenue Declines

Biospace news - Thu, 10/26/2023 - 02:00
BMS Pushes Back Target Sales for New Drugs as Q3 Revenue Declines 10/26/2023

Takeda Reports $770M Write-Down, Cuts Profit Forecast by 71% for FY2023

Biospace news - Thu, 10/26/2023 - 02:00
Takeda Reports $770M Write-Down, Cuts Profit Forecast by 71% for FY2023 10/26/2023

Eisai, Biogen Build Case for Subcutaneous Leqembi for Alzheimer’s at CTAD

Biospace news - Thu, 10/26/2023 - 02:00
Eisai, Biogen Build Case for Subcutaneous Leqembi for Alzheimer’s at CTAD 10/26/2023

Alnylam Publishes Phase III ATTR-CM Data for Patisiran After FDA Rejection

Biospace news - Thu, 10/26/2023 - 02:00
Alnylam Publishes Phase III ATTR-CM Data for Patisiran After FDA Rejection 10/26/2023

BioXcel Alzheimer’s Trial Shows No Signs of Misconduct, Finds Independent Audit

Biospace news - Thu, 10/26/2023 - 02:00
BioXcel Alzheimer’s Trial Shows No Signs of Misconduct, Finds Independent Audit 10/26/2023

How the Pandemic Shifted the Rules of Recruiting

Biospace news - Thu, 10/26/2023 - 02:00
How the Pandemic Shifted the Rules of Recruiting 10/26/2023

Candidates Expect More than the Job Market Can Deliver

Biospace news - Thu, 10/26/2023 - 02:00
Candidates Expect More than the Job Market Can Deliver 10/26/2023

Araclon’s Alzheimer’s Vaccine Shows Clean Safety Profile in Phase II Analysis

Biospace news - Wed, 10/25/2023 - 02:00
Araclon’s Alzheimer’s Vaccine Shows Clean Safety Profile in Phase II Analysis 10/25/2023

GSK Looks to Push RSV Vaccine to Younger Seniors with New Phase III Data

Biospace news - Wed, 10/25/2023 - 02:00
GSK Looks to Push RSV Vaccine to Younger Seniors with New Phase III Data 10/25/2023